lobbying_activities: 1161112

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1161112	a3628046-2bcc-47fc-9afd-7070ec87dab5	Q3	ASSOCIATION FOR ACCESSIBLE MEDICINES	16032	ASSOCIATION FOR ACCESSIBLE MEDICINES	2011	third_quarter	PHA	FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011	Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office		548315	0	0	2011-10-19T16:34:06.983000-04:00